Why Biogen Shares Rose 2.59% in March
Stocks entered a bear market in March, but shares of Biogen (NASDAQ: BIIB) moved higher, rising 2.59% during the month, according to data provided by S&P Global Market Intelligence. Biogen gained as investors sought out shares of companies perceived as safe havens during the coronavirus outbreak.
The biotechnology giant last month said it didn't expect manufacturing or supply interruptions and didn't announce any immediate impact on its financial outlook. The company said the timeline of some clinical trials might be altered due to the situation, but so far, trials already underway are continuing as planned.
Image source: Getty Images.
Source Fool.com
